TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive In Brief: Wittes To Become Acting DCT Director; Kaufman Leaves NCI For Private Practice February 17, 1995
TCL Archive News Organizations Protest invitation-Only Press Conferences, Exclusion of Reporters May 20, 1994